STO advances global oncology and patient care by bridging scientific discovery and clinical application, promoting equitable healthcare, and harmonizing cancer trials and regulatory standards to ensure swift access to life-saving treatments worldwide. Society for Translational Oncology: A Global Mission
The Society for Translational Oncology (STO), a 501(c)(3) not-for-profit organization, is dedic
ated to advancing global oncology and improving patient care by bridging the gap between scientific discovery and clinical application. Committed to diversity, inclusivity, and equity, STO empowers healthcare professionals with the knowledge and tools to implement cutting-edge cancer therapies and improve patient outcomes worldwide. Through strategic guidance and global alliances, we work to harmonize cancer clinical trials and regulatory standards, ensuring that life-saving treatments are speedily accessible to all patients with cancer. STO Continuing Medical Education Mission
STO is committed to providing impactful education to oncology physicians, with the goal of improving the quality and safety of care for patients with cancer. This mission will be fulfilled by offering relevant and effective continuing medical education programs, focusing on:
Knowledge and strategies for implementation of critical new developments in cancer treatment, screening, and prevention
The translational gap between research, discovery and delivery of care to the patient, providing content that is evidence-based and within the discipline of clinical medicine
Educational activities that are relevant and impact the practice of physicians within an oncology team in collaboration with nurses, pharmacists and other oncology healthcare professionals
